Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
24 participants
INTERVENTIONAL
2005-10-31
2006-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Field of Effects of Two Commercial Preparations of Botulinum Toxin Type A
NCT00989768
Comparison of Two Commercial Preparations of Botulinum Toxin Type A
NCT00959907
Phase IV Study On Muscle Activity Of Two Commercial Preparations Of Botulinum
NCT01728337
Post Marketing Surveillance Study of Dysport
NCT00210431
Treatment of Forehead/Glabellar Rhytide Complex With Combination Botulinum Toxin A and Hyaluronic Acid Versus Botulinum Toxin A Injection Alone
NCT01186835
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
botulinum toxin type A
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* moderate to severe hyperfunctional forehead wrinkles at maximum contraction and at rest
Exclusion Criteria
* any significant health disturbances
* facial nerve palsy, and any facial conditions that could confound safety or efficacy results
* pregnancy and breast-feeding
* neuromuscular diseases
* drugs interfering with neuromuscular function (e.g. aminoglycosides)
30 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Laserklinik Karlsruhe
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Syrus Karsai, MD
Role: PRINCIPAL_INVESTIGATOR
Laserklinik Karlsruhe
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Laserklinik Karlsruhe
Karlsruhe, Baden-Wurttemberg, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CR-015-LK/2005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.